IP6K1 Rewires LKB1 Signaling to Mediate Hyperglycemic Endothelial Senescence

Diabetes is a major risk factor for cardiovascular diseases. The mechanisms of hyperglycemia-induced endothelial dysfunction have been elusive. We found that inositol hexakisphosphate kinase 1 (IP6K1) mediates hyperglycemia-induced endothelial senescence by switching liver kinase B1 (LKB1) activation of the AMPK pathway to activation of the p53 pathway. Hyperglycemia upregulates IP6K1, which stabilizes LKB1 by disrupting Hsp/Hsc70 and carboxyl terminus of Hsc70-interacting protein-mediated LKB1 degradation but suppresses LKB1-dependent AMPK activation. Elevated LKB1 binds more to p53, resulting in p53-dependent endothelial senescence. Endothelial cell-specific deletion of IP6K1 attenuates, whereas endothelial cell-specific overexpression of IP6K1 exaggerates, hyperglycemia-induced endothelial senescence.

Authors

Institutions

Publication Details

Journal
Diabetes
Published
2025-01-10
DOI
https://doi.org/10.2337/db24-0706
Citations
1
Primary Topic
Metabolism, Diabetes, and Cancer
Type
article
Field-Weighted Citation Impact
0.81
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

IP6K1 Rewires LKB1 Signaling to Mediate Hyperglycemic Endothelial Senescence

Dorothea Fiedler, Chenglai Fu, Tim Aguirre, Alfred C. Chin et al.
1 citations
Diabetes
Metabolism, Diabetes, and Cancer
0.81
article

IP6K1 Rewires LKB1 Signaling to Mediate Hyperglycemic Endothelial Senescence

Dorothea Fiedler, Chenglai Fu, Tim Aguirre, Alfred C. Chin, Yue Liu, Yuanyuan Chen, Ji Qi, Hong Zhu, Changchang Xing, Alex F. Chen, Linhui Shi, Limei Zhu
article en
1 citations

Abstract

Diabetes is a major risk factor for cardiovascular diseases. The mechanisms of hyperglycemia-induced endothelial dysfunction have been elusive. We found that inositol hexakisphosphate kinase 1 (IP6K1) mediates hyperglycemia-induced endothelial senescence by switching liver kinase B1 (LKB1) activation of the AMPK pathway to activation of the p53 pathway. Hyperglycemia upregulates IP6K1, which stabilizes LKB1 by disrupting Hsp/Hsc70 and carboxyl terminus of Hsc70-interacting protein-mediated LKB1 degradation but suppresses LKB1-dependent AMPK activation. Elevated LKB1 binds more to p53, resulting in p53-dependent endothelial senescence. Endothelial cell-specific deletion of IP6K1 attenuates, whereas endothelial cell-specific overexpression of IP6K1 exaggerates, hyperglycemia-induced endothelial senescence.

DiabetesVol. 74(4)
Ningbo University (CN), Memorial Sloan Kettering Cancer Center (US), Cornell University (US), XinHua Hospital (CN), Leibniz-Forschungsinstitut für Molekulare Pharmakologie (DE), Tri-Institutional PhD Program in Chemical Biology (US), Ningbo Medical Center Lihuili Hospital (CN), Ningbo No.6 Hospital (CN)
Good health and well-being
Openalex Percentile: Top 32%
Metabolism, Diabetes, and Cancer
0.81
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

IP6K1 Rewires LKB1 Signaling to Mediate Hyperglycemic Endothelial Senescence — Dorothea Fiedler, Chenglai Fu, et al. · Diabetes (2025) | TGRS Research Map | TGRS